Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Romeijn

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|January 31, 2004
Phylogenetic analysis of the highland papayas ( Vasconcellea) and allied genera (Caricaceae) using PCR-RFLPB Van Droogenbroeck, T Kyndt, I Maertens, et al.
The British Journal of Dermatology|January 23, 2024
The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in childrenAviël Ragamin, Junfen Zhang, Suzanne G M A Pasmans, et al.
The Journal of Dermatological Treatment|June 21, 2021
Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab - a cross-sectional study from the BioDay registryJart A F Oosterhaven, Lotte S Spekhorst, Junfen Zhang, et al.
Allergy|July 15, 2022
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitisLotte S Spekhorst, Daphne Bakker, Julia Drylewicz, et al.
Experimental Dermatology|July 12, 2021
Vesicular hand eczema transcriptome analysis provides insights into its pathophysiologyAngelique N Voorberg, Hanna Niehues, Jart A F Oosterhaven, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 24, 2022
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registryEsmé Kamphuis, Celeste M Boesjes, Laura Loman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 25, 2023
Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert surveyHenriette Rönsch, Frederike Schiffers, Robert Ofenloch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 23, 2023
Chronic hand eczema in Europe: Patient experiences and perspectives (CHEPEP) in qualitative interviewsH Rönsch, F Schiffers, R Ofenloch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2019
Defining and measuring 'eczema control': an international qualitative study to explore the views of those living with and treating atopic eczemaL Howells, K S Thomas, A V Sears, et al.
Journal of the American Academy of Dermatology|September 18, 2020
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registryLieneke F M Ariëns, Jorien van der Schaft, Lotte S Spekhorst, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|January 31, 2004
Phylogenetic analysis of the highland papayas ( Vasconcellea) and allied genera (Caricaceae) using PCR-RFLPB Van Droogenbroeck, T Kyndt, I Maertens, et al.
The British Journal of Dermatology|January 23, 2024
The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in childrenAviël Ragamin, Junfen Zhang, Suzanne G M A Pasmans, et al.
The Journal of Dermatological Treatment|June 21, 2021
Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab - a cross-sectional study from the BioDay registryJart A F Oosterhaven, Lotte S Spekhorst, Junfen Zhang, et al.
Allergy|July 15, 2022
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitisLotte S Spekhorst, Daphne Bakker, Julia Drylewicz, et al.
Experimental Dermatology|July 12, 2021
Vesicular hand eczema transcriptome analysis provides insights into its pathophysiologyAngelique N Voorberg, Hanna Niehues, Jart A F Oosterhaven, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 24, 2022
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registryEsmé Kamphuis, Celeste M Boesjes, Laura Loman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 25, 2023
Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert surveyHenriette Rönsch, Frederike Schiffers, Robert Ofenloch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 23, 2023
Chronic hand eczema in Europe: Patient experiences and perspectives (CHEPEP) in qualitative interviewsH Rönsch, F Schiffers, R Ofenloch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2019
Defining and measuring 'eczema control': an international qualitative study to explore the views of those living with and treating atopic eczemaL Howells, K S Thomas, A V Sears, et al.
Journal of the American Academy of Dermatology|September 18, 2020
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registryLieneke F M Ariëns, Jorien van der Schaft, Lotte S Spekhorst, et al.
Pageof 3